This thesis explores the strategies of ignorance and uncertainty employed by UK regulators, practitioners and policymakers during the controversy over whether selective serotonin reuptake inhibitor (SSRI) antidepressants such as Prozac contribute to suicidal and homicidal reactions in some users. Empirically, the thesis is based on archival research, textual analysis, and interviews with UK policymakers and clinicians involved with efforts to determine the safety of SSRIs. By analyzing these materials with methodological and conceptual tools from the fields of science studies and the sociology of reason and objectivity, the thesis demonstrates the following four findings. First, drawing on the case of SSRIs, I demonstrate that many policyma...
This thesis addresses several controversial issues regarding commonly used antidepressants, includin...
Randomised controlled trials form a central building block within the prevailing evidence-based ment...
There is an abundance of research on the psychopharmacological treatment of depression. However, rec...
Drawing on narrative interviews with psychiatrists and health analysts in Britain, the article provi...
Drawing on an analysis of Irving Kirsch and colleagues? controversial 2008 article in PLoS [Public L...
Recent controversies over the safety of drugs such as Vioxx, a painkiller manufactured by Merck, and...
While Prozac initially came to be termed the ‘wonder-drug’ for adults suffering from depression, the...
In the 1990s the estimated prevalence of depression was two thousand times higher than in the 1960s ...
The debate over antidepressants, especially SSRIs, has lasted for more than a decade, the controvers...
During the last decade, there was a debate concerning the true efficacy of antidepressants. Several ...
Before obtaining a marketing approval, the efficacy and safety profile of drugs is studied in specif...
Background: Concern exists that childhood and adolescent major depressive disorder is increasing, al...
Abstract Background Systematic reviews of randomised placebo controlled trials of antidepressant med...
© Monash University, Centre for Human BioethicsThe creation of pharmacotherapies, such as Selective ...
BACKGROUND: Depression is the leading cause of disability worldwide, and is a major contributor to t...
This thesis addresses several controversial issues regarding commonly used antidepressants, includin...
Randomised controlled trials form a central building block within the prevailing evidence-based ment...
There is an abundance of research on the psychopharmacological treatment of depression. However, rec...
Drawing on narrative interviews with psychiatrists and health analysts in Britain, the article provi...
Drawing on an analysis of Irving Kirsch and colleagues? controversial 2008 article in PLoS [Public L...
Recent controversies over the safety of drugs such as Vioxx, a painkiller manufactured by Merck, and...
While Prozac initially came to be termed the ‘wonder-drug’ for adults suffering from depression, the...
In the 1990s the estimated prevalence of depression was two thousand times higher than in the 1960s ...
The debate over antidepressants, especially SSRIs, has lasted for more than a decade, the controvers...
During the last decade, there was a debate concerning the true efficacy of antidepressants. Several ...
Before obtaining a marketing approval, the efficacy and safety profile of drugs is studied in specif...
Background: Concern exists that childhood and adolescent major depressive disorder is increasing, al...
Abstract Background Systematic reviews of randomised placebo controlled trials of antidepressant med...
© Monash University, Centre for Human BioethicsThe creation of pharmacotherapies, such as Selective ...
BACKGROUND: Depression is the leading cause of disability worldwide, and is a major contributor to t...
This thesis addresses several controversial issues regarding commonly used antidepressants, includin...
Randomised controlled trials form a central building block within the prevailing evidence-based ment...
There is an abundance of research on the psychopharmacological treatment of depression. However, rec...